Aton (BST:3HB)

Germany flag Germany · Delayed Price · Currency is EUR
0.0166
+0.0062 (59.62%)
At close: Apr 27, 2026
277.27%
Market Cap 17.06M
Revenue (ttm) 656.93K
Net Income (ttm) -115.68K
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 500
Open 0.0072
Previous Close 0.0104
Day's Range 0.0070 - 0.0252
52-Week Range 0.0002 - 0.0252
Beta n/a
RSI 68.94
Earnings Date Apr 29, 2026

About Aton

Aton operates as a bioscience company in France. It engages in drug development, preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company also offers medical devices for surgeons, powered by Stemcis. The company was founded in 1998 and is headquartered in Strasbourg, France. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1998
Employees 9
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol 3HB
Full Company Profile

Financial Performance

In 2024, Aton's revenue was 614,000, an increase of 0.33% compared to the previous year's 612,000. Losses were -1.10 million, -86.01% less than in 2023.

News

There is no news available yet.